{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:00:26Z","timestamp":1792400426400,"version":"4.4.0"},"reference-count":65,"publisher":"Informa UK Limited","issue":"7","funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"crossref","award":["2018YFC160390"],"award-info":[{"award-number":["2018YFC160390"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.1080\/21645515.2020.1857201","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T01:31:44Z","timestamp":1613352704000},"page":"2197-2204","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Meningococcal vaccines in China"],"prefix":"10.1080","volume":"17","author":[{"given":"Yinghua","family":"Xu","sequence":"first","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoguang","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ye","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0524-6"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1904.111799"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/504804"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ampbs.2015.05.001"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-11-17"},{"key":"e_1_3_3_8_1","first-page":"19","article-title":"Group A meningococcal polysaccharide vaccine widely used in China","volume":"6","author":"Ding SQ","year":"1981","unstructured":"Ding SQ. Group A meningococcal polysaccharide vaccine widely used in China. Bull Med Res. 1981;6:19.","journal-title":"Bull Med Res"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1012503"},{"key":"e_1_3_3_10_1","first-page":"159","article-title":"Analysis of epidemic characteristics for meningococcal meningitis in China during 2015-2017","volume":"53","author":"Li JH","year":"2019","unstructured":"Li JH, Wu D, Yin ZD, Li YX. Analysis of epidemic characteristics for meningococcal meningitis in China during 2015-2017. Zhonghua yu fang yi xue za zhi [Chin J Prev Med]. 2019;53:159\u201363.","journal-title":"Zhonghua yu fang yi xue za zhi [Chin J Prev Med]"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.01.007"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.10.072"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.06.020409"},{"key":"e_1_3_3_14_1","unstructured":"Ling J Li Y Luo H. Prevention and control of epidemic meningococcal meningitis. Disease surveillance. 2009;24:155\u201359."},{"key":"e_1_3_3_15_1","first-page":"541","article-title":"Epidemiologic trend of serogroup switching of Neisseria meningitidis strains in China","volume":"13","author":"Shao Z","year":"2007","unstructured":"Shao Z, Xu L, Gao Y, Li M, Li Y, Yin Z, Liang X. Epidemiologic trend of serogroup switching of Neisseria meningitidis strains in China. Chin J Vaccin Immun. 2007;13:541\u201344.","journal-title":"Chin J Vaccin Immun"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68141-5"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47263-0"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.07.022"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.140687"},{"key":"e_1_3_3_20_1","first-page":"153","article-title":"Molecular characteristics of serogroup B neisseria meningitidis, China","volume":"53","author":"Zhu BQ","year":"2019","unstructured":"Zhu BQ, Gao WY, Xu L, Gao Y, Shao ZJ. Molecular characteristics of serogroup B neisseria meningitidis, China. Zhonghua yu fang yi xue za zhi [Chin J Prev Med]. 2019;53:153\u201358.","journal-title":"Zhonghua yu fang yi xue za zhi [Chin J Prev Med]"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2404.171744"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.08.022"},{"key":"e_1_3_3_23_1","first-page":"825","article-title":"Epidemiological analysis on serogroup Y neisseria meningitidis firstly isolated from patient in Tianjin","volume":"50","author":"Guo LC","year":"2016","unstructured":"Guo LC, Liu XC, Xu QY, Yiu YS Cai Y Jiang GQ Shao Z. Epidemiological analysis on serogroup Y neisseria meningitidis firstly isolated from patient in Tianjin. Zhonghua yu fang yi xue za zhi [Chin J Prev Med]. 2016;50:825\u201327.","journal-title":"Zhonghua yu fang yi xue za zhi [Chin J Prev Med]"},{"key":"e_1_3_3_24_1","first-page":"521","article-title":"World Health Organization. Meningococcal vaccines: WHO position paper, November 2011","volume":"86","year":"2011","unstructured":"World Health Organization. Meningococcal vaccines: WHO position paper, November 2011. Releve epidemiologique hebdomadaire. 2011; 86:521\u201339.","journal-title":"Releve epidemiologique hebdomadaire"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"e_1_3_3_26_1","first-page":"601","article-title":"Reported coverage of vaccine in the national Immunizaiton program of China, 2015","volume":"23","author":"Cui J","year":"2017","unstructured":"Cui J, Cao L, Zheng J, Cao L, Duan M, Xiao Q. Reported coverage of vaccine in the national Immunizaiton program of China, 2015. Chin J Vaccin Immun. 2017;23:601\u201307.","journal-title":"Chin J Vaccin Immun"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1349"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108235"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.1.200"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200002000-00013"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.21.2795"},{"key":"e_1_3_3_33_1","first-page":"1768","article-title":"The efficacy and safety of A,C,W135,Y Meningococcal polysaccharide vaccines","volume":"14","author":"Wu C","year":"2007","unstructured":"Wu C, Wang Y, Hang J, Xu J, Yuan W, Ma F, Tao H, Gong P. The efficacy and safety of A,C,W135,Y Meningococcal polysaccharide vaccines. Pract Prev Med. 2007;14:1768\u201370.","journal-title":"Pract Prev Med"},{"key":"e_1_3_3_34_1","first-page":"667","article-title":"A controlled field trial of a serogroup A meningococcal polysaccharide vaccine","volume":"48","author":"Wahdan MH","year":"1973","unstructured":"Wahdan MH, Rizk F, el-Akkad AM, el-Ghoroury AA, Hablas R, Girgis NI, Amer A, Boctar W, Sippel JE, Gotschlich EC, et al. A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull World Health Organ. 1973;48:667\u201373.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197709292971302"},{"key":"e_1_3_3_36_1","first-page":"4","article-title":"Immunizing reactivity following vaccination with a purified fraction of Neisseria meningitidis and observations of effectiveness throughout 3 years","volume":"3","author":"Wei RT","year":"1982","unstructured":"Wei RT. Immunizing reactivity following vaccination with a purified fraction of Neisseria meningitidis and observations of effectiveness throughout 3 years. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 1982;3:4\u20137.","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"key":"e_1_3_3_37_1","first-page":"69","article-title":"Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method","volume":"12","author":"Ma Z","year":"1991","unstructured":"Ma Z. Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 1991;12:69\u201371.","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"key":"e_1_3_3_38_1","first-page":"338","article-title":"Observation on the injection reaction and immunogenicity of group A+C meningococcal polysaccharide vaccine","volume":"12","author":"Yang J","year":"2006","unstructured":"Yang J, Gong J, Liao Z. Observation on the injection reaction and immunogenicity of group A+C meningococcal polysaccharide vaccine. Applied Prev Med. 2006;12:338\u201342.","journal-title":"Applied Prev Med"},{"key":"e_1_3_3_39_1","first-page":"483","article-title":"Preparation of group A+ C meningococcal polysaccharide conjugate vaccine","volume":"18","author":"Huang Z","year":"2005","unstructured":"Huang Z, QIan W, Yuan L, Chen Y, Cheng N, Zhou H, Li W, Yang M, Liu H. Preparation of group A+ C meningococcal polysaccharide conjugate vaccine. Chin J Biol. 2005;18:483\u201386.","journal-title":"Chin J Biol"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.76.1.91"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.42.2.599-604.1983"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2003.07.008"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530430043037"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003812"},{"key":"e_1_3_3_45_1","first-page":"901","article-title":"Minutes of the meningococcal meningitis surveillance and immunization prevention seminar","volume":"16","author":"Chai Z","year":"2015","unstructured":"Chai Z, Li J, Shao Z, Li F, Diao L, Li L, Yin Z. Minutes of the meningococcal meningitis surveillance and immunization prevention seminar. Chin Prev Med. 2015;16:901\u201303.","journal-title":"Chin Prev Med"},{"key":"e_1_3_3_46_1","first-page":"531","article-title":"Study on safety and immunogenicity of group A\/C meningococcal polysaccharide conjugate vaccine","volume":"15","author":"Tao H","year":"2009","unstructured":"Tao H, Li Y, Wu C, Ye Q, Hong J, Xu J, Yuan W, Ma F. Study on safety and immunogenicity of group A\/C meningococcal polysaccharide conjugate vaccine. Chin J Vaccin Immun. 2009;15:531\u201335.","journal-title":"Chin J Vaccin Immun"},{"key":"e_1_3_3_47_1","first-page":"920","article-title":"Evaluation of safety of meningococcal group AC bivalent polysaccharide conjugate vaccine in children aged 5-24 months old","volume":"47","author":"Zhou H","year":"2013","unstructured":"Zhou H, Wang JY, Tan Y, Lu HY, Wang M, Cai QC, Zhang HZ. Evaluation of safety of meningococcal group AC bivalent polysaccharide conjugate vaccine in children aged 5-24 months old. Zhonghua yu fang yi xue za zhi [Chin J Prev Med]. 2013;47:920\u201323.","journal-title":"Zhonghua yu fang yi xue za zhi [Chin J Prev Med]"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26347"},{"key":"e_1_3_3_49_1","first-page":"707","article-title":"Immunogenicity and immune persistence of groups A&C meningococcal polysaccharide conjugate vaccine","volume":"28","author":"Zheng J","year":"2015","unstructured":"Zheng J, Zhu X, Liu G, Du L. Immunogenicity and immune persistence of groups A&C meningococcal polysaccharide conjugate vaccine. Chin J Biol July. 2015;28:707\u201310.","journal-title":"Chin J Biol July"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1303380"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1033592"},{"key":"e_1_3_3_52_1","first-page":"578","article-title":"Safety of post-marketing group A and C meningococcal conjugate and haemophilus type b conjugate combined vaccine among children aged 2-71 months","volume":"22","author":"Li J","year":"2016","unstructured":"Li J, Yang J, Liu X, Shi K, Yang H, Zheng W, Li S, Liu A, Zhang Z. Safety of post-marketing group A and C meningococcal conjugate and haemophilus type b conjugate combined vaccine among children aged 2-71 months. Chin J Vaccin Immun. 2016;22:578\u201381.","journal-title":"Chin J Vaccin Immun"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1458175"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90340-9"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24129"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1547637"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30048-3"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31921-3"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1483726"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30314-0"},{"key":"e_1_3_3_61_1","first-page":"523","article-title":"Study on improvement of national lot release regulations on biological products","volume":"24","author":"Jia L","year":"2010","unstructured":"Jia L, Yang R, Dong G. Study on improvement of national lot release regulations on biological products. Chin Pharm Affairs. 2010;24:523\u201330.","journal-title":"Chin Pharm Affairs"},{"key":"e_1_3_3_62_1","volume-title":"National pharmacopoeia committee.The Chinese pharmacopoeia (2020 version) 3rd part","year":"2020","unstructured":"National pharmacopoeia committee.The Chinese pharmacopoeia (2020 version) 3rd part. Beijing (China): Chinese Medical Science and Technology Press; 2020."},{"key":"e_1_3_3_63_1","first-page":"657","article-title":"Trend analysis and quality evaluation for Group ACYW meningococcal polysaccharide vaccine in China","volume":"28","author":"Li Y","year":"2005","unstructured":"Li Y, Zhao D, Li M, Li H, Liang L, Ye Q, Chen C. Trend analysis and quality evaluation for Group ACYW meningococcal polysaccharide vaccine in China. Chin J Biol. 2005;28:657\u201361.","journal-title":"Chin J Biol"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.098"},{"key":"e_1_3_3_65_1","first-page":"645","article-title":"Development and verification of immune rate turbidimetric method for quantitative determination of polysaccharide content in groups A and C meningococcus and Haemophilus influenzae type b combined vaccine","volume":"30","author":"Li Y","year":"2017","unstructured":"Li Y, Zhu X, Ma Q, Cheng S, Zhao D, Wang S. Development and verification of immune rate turbidimetric method for quantitative determination of polysaccharide content in groups A and C meningococcus and Haemophilus influenzae type b combined vaccine. Chin J Biol. 2017;30:645\u201348.","journal-title":"Chin J Biol"},{"key":"e_1_3_3_66_1","first-page":"141","article-title":"Chinese preventive medicine A. [Experts\u2019 consensus on immunization with meningococcal vaccines in China]","volume":"53","year":"2019","unstructured":"Wu J, Li J, Li Y, Shao Z, Li J, Zhu B, Wu D, Yao K, Liu G, Ye Q, et al. Chinese preventive medicine A. [Experts\u2019 consensus on immunization with meningococcal vaccines in China]. Zhonghua yu fang yi xue za zhi [Chin J Prev Med]. 2019; 53:141\u201345.","journal-title":"Zhonghua yu fang yi xue za zhi [Chin J Prev Med]"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1857201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:05:01Z","timestamp":1709305501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1857201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,3]]}},"alternative-id":["10.1080\/21645515.2020.1857201"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1857201","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}